638
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Application of the ESHO-QA guidelines for determining the performance of the LCA superficial hyperthermia heating system

, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Article: 2272578 | Received 03 May 2023, Accepted 15 Oct 2023, Published online: 25 Oct 2023

References

  • Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys. 1996;35(4):731–744. doi: 10.1016/0360-3016(96)00154-x.
  • Harima Y, Ohguri T, Imada H, et al. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hyperthermia. 2016;32(7):801–808. doi: 10.1080/02656736.2016.1213430.
  • Issels RD, Lindner LH, Wessalowski R, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2017;18(11):e630–570. doi: 10.1016/S1470-2045(10)70071-1.
  • Issels RD, Lindner LH, Verweij J, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. JAMA Oncol. 2018;4(4):483–492. doi: 10.1001/jamaoncol.2017.4996.
  • Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet. 1995;345(8949):540–543. doi: 10.1016/s0140-6736(95)90463-8.
  • Perez CA, Pajak T, Emami B, et al. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the radiation therapy oncology group. Am J Clin Oncol. 1991;14(2):133–141. doi: 10.1097/00000421-199104000-00008.
  • van der Zee J, González González D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet. 2000;355(9210):1119–1125. doi: 10.1016/s0140-6736(00)02059-6.
  • Vasanthan A, Mitsumori M, Park JH, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys. 2005;61(1):145–153. doi: 10.1016/j.ijrobp.2004.04.057.
  • Datta NR, Rogers S, Ordóñez SG, et al. Hyperthermia and radiotherapy in the management of head and neck cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2016;32(1):31–40. doi: 10.3109/02656736.2015.1099746.
  • Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073–1087. doi: 10.1016/j.ijrobp.2015.12.361.
  • Datta NR, Stutz E, Gomez S, et al. Efficacy and safety evaluation of the various therapeutic options in locally advanced cervix cancer: a systematic review and network meta-analysis of randomized clinical trials. Int J Radiat Oncol Biol Phys. 2019;103(2):411–437. doi: 10.1016/j.ijrobp.2018.09.037.
  • Oleson JR, Samulski TV, Leopold KA, et al. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys. 1993;25(2):289–297. doi: 10.1016/0360-3016(93)90351-u.
  • Sherar M, Liu FF, Pintilie M, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys. 1997;39(2):371–380. doi: 10.1016/s0360-3016(97)00333-7.
  • Issels RD, Mittermüller J, Gerl A, et al. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients. J Cancer Res Clin Oncol. 1991;117 Suppl 4(S4):S141–S147. doi: 10.1007/BF01613220.
  • Rau B, Wust P, Tilly W, et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys. 2000;48(2):381–391. doi: 10.1016/s0360-3016(00)00650-7.
  • Franckena M, Fatehi D, de Bruijne M, et al. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer. 2009;45(11):1969–1978. doi: 10.1016/j.ejca.2009.03.009.
  • Kroesen M, Mulder HT, van Holthe JML, et al. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia. Radiother Oncol. 2019;140:150–158. doi: 10.1016/j.radonc.2019.06.021.
  • Willner A, Fechner K, Agaimy A, et al. Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome. Strahlenther Onkol. 2021;197(12):1063–1071. doi: 10.1007/s00066-021-01830-0.
  • Dobšíček Trefná H, Crezee J, Schmidt M, et al. Quality assurance guidelines for superficial hyperthermia clinical trials: II. Technical requirements for heating devices. Strahlenther Onkol. 2017;193(5):351–366. doi: 10.1007/s00066-017-1106-0.
  • Hand JW, Lagendijk JJ, Bach Andersen J, et al. Quality assurance guidelines for ESHO protocols. Int J Hyperthermia. 1989;5(4):421–428. doi: 10.3109/02656738909140469.
  • Dobšíček Trefná H, Schmidt M, van Rhoon GC, et al. Quality assurance guidelines for interstitial hyperthermia. International Journal of Hyperthermia. 2019;36(1):276–293. doi: 10.1080/02656736.2018.1564155.
  • Van Der Zee J, De Bruijne M, Mens JWM, et al. Reirradiation combined with hyperthermia in breast cancer recurrences: overview of experience in erasmus MC. Int J Hyperthermia. 2010;26(7):638–648. doi: 10.3109/02656736.2010.495104.
  • van der Zee J, van der Holt B, Rietveld PJ, et al. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer. 1999;79(3-4):483–490. doi: 10.1038/sj.bjc.6690075.
  • Linthorst M, van Geel AN, Baaijens M, et al. Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiother Oncol. 2013;109(2):188–193. doi: 10.1016/j.radonc.2013.05.010.
  • Linthorst M, Baaijens M, Wiggenraad R, et al. Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol. 2015;117(2):217–222. doi: 10.1016/j.radonc.2015.04.019.
  • Van Rhoon G, Rietveld P, Van der Zee J. A 433 MHz lucite cone waveguide applicator for superficial hyperthermia. Int J Hyperthermia. 1998;14(1):13–27. doi: 10.3109/02656739809018211.
  • Rietveld PJ, van Putten WL, van der Zee J, et al. Comparison of the clinical effectiveness of the 433 MHz lucite cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia. Int J Radiat Oncol Biol Phys. 1999;43(3):681–687. doi: 10.1016/s0360-3016(98)00443-x.
  • Rietveld PJ, Lumori ML, van der Zee J, et al. Quantitative evaluation of arrays of lucite cone applicators in flat layered phantoms using gaussian-beam-predicted and thermographically measured SAR distributions. Phys Med Biol. 1998;43(8):2207–2220. doi: 10.1088/0031-9155/43/8/015.
  • de Bruijne M, Wielheesen DHM, van der Zee J, et al. Benefits of superficial hyperthermia treatment planning: five case studies. Int J Hyperthermia. 2007;23(5):417–429. doi: 10.1080/02656730701502077.
  • Samaras T, Rietveld P, Van Rhoon G. Effectiveness of FDTD in predicting SAR distributions from the lucite cone applicator. IEEE Trans Microwave Theory Techn. 2000;48(11):2059–2063. doi: 10.1109/22.884195.
  • De Lazzari M, Ström A, Farina L, et al. Ethylcellulose-stabilized fat-tissue phantom for quality assurance in clinical hyperthermia. Int J Hyperthermia. 2023;40(1):2207797. doi: 10.1080/02656736.2023.2207797.
  • Schaubert D. Electromagnetic heating of tissue‐equivalent phantoms with thin, insulating partitions. Bioelectromagnetics. 1984;5(2):221–232. doi: 10.1002/bem.2250050210.
  • La Gioia A, Porter E, Merunka I, et al. Open-ended coaxial probe technique for dielectric measurement of biological tissues: challenges and common practices. Diagnostics. 2018;8(2):40. doi: 10.3390/diagnostics8020040.
  • Silva NP, Bottiglieri A, Conceição RC, et al. Characterisation of ex vivo liver thermal properties for electromagnetic-based hyperthermic therapies. Sensors. 2020;20(10):3004. doi: 10.3390/s20103004.
  • Van der Gaag ML, De Bruijne M, Samaras T, et al. Development of a guideline for the water bolus temperature in superficial hyperthermia. Int J Hyperthermia. 2006;22(8):637–656. doi: 10.1080/02656730601074409.
  • Hasgall PA, Di Gennaro F, Baumgartner C, et al. IT’IS Database for thermal and electromagnetic parameters of biological tissues. Version 4.1. 2022. doi: 10.13099/VIP21000-04-1.
  • Drizdal T, Paulides MM, Sumser K, et al. Application of photogrammetry reconstruction for hyperthermia quality control measurements. Phys Med. 2022;101:87–94. doi: 10.1016/j.ejmp.2022.08.008.